Showing results (921-930 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|June 12, 2013
Developmental changes in morphine clearance across the entire paediatric age range are best described by a bodyweight-dependent exponent modelChenguang Wang, Senthilkumar Sadhavisvam, Elke H J Krekels, et al.
Clinical Drug Investigation|June 7, 2013
Treatment of Morton neuroma with botulinum toxin A: a pilot studyJosé M Climent, Francisco Mondéjar-Gómez, Carmen Rodríguez-Ruiz, et al.
Clinical Drug Investigation|November 1, 2013
A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac diseaseMasaharu Hirano, Akira Yamashina, Kazuhiro Hara, et al.
Clinical Drug Investigation|November 2, 2013
Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studiesHiromi Iitsuka, Tomoaki Tokuno, Yoko Amada, et al.
Clinical Drug Investigation|November 13, 2013
Pharmacokinetics, pharmacodynamics, and immunogenicity of belatacept in adult kidney transplant recipientsJinshan Shen, Robert Townsend, Xiaoli You, et al.
Clinical Drug Investigation|October 19, 2013
Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysisCarla Rognoni, Monia Marchetti, Silvana Quaglini, et al.
Clinical Drug Investigation|October 18, 2013
An open-label drug-drug interaction study of the steady-state pharmacokinetics of topiramate and glyburide in patients with type 2 diabetes mellitusPrasarn Manitpisitkul, Christopher R Curtin, Kevin Shalayda, et al.
Clinical Drug Investigation|September 27, 2013
The effect of active vitamin D administration on muscle mass in hemodialysis patientsAtsushi Mori, Tomoya Nishino, Yoko Obata, et al.
Clinical Drug Investigation|October 1, 2013
Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjectsLi Young Ahn, Kwang-Hee Shin, Kyoung Soo Lim, et al.
Clinical Drug Investigation|October 3, 2013
Adding pregabalin or gabapentin for the management of community-treated patients with painful diabetic peripheral neuropathy: a comparative cost analysisAntoni Sicras, Javier Rejas, Ruth Navarro, et al.
Pageof 234